ArticleJournal of cellular and molecular medicine2015

Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib.

Eva Juengel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.